Literature DB >> 25168417

[Influence of ECMO and IABP on coronary blood flow. Valuable combination or waste of resources?].

T Schroeter1, M Vollroth, M Höbartner, M Sauer, M Mende, F W Mohr, M Misfeld.   

Abstract

BACKGROUND: The treatment of patients in severe cardiogenic shock with an intra-aortic balloon pump (IABP) or extracorporeal membrane oxygenation (ECMO) is a common procedure to achieve stabilization. Only limited data are available on the simultaneous use of both systems. The aim of the present study was to assess the effect of the concomitant use of IABP and ECMO on coronary blood flow. In addition, the influence of antegrade and retrograde perfusion was evaluated.
METHODS: A median sternotomy was performed in adult pigs under general anesthesia. Arterial ECMO perfusion was realized through the ascending aorta or the femoral artery, and the IABP was implanted via the second femoral artery. Six measurements of arterial pressure in the left anterior descending artery (LAD) and in the left atrium were made at intervals of 2 min. In addition, lactate concentration and oxygen saturation in the coronary sinus were recorded. The ECMO support was either 100 or 50 % of cardiac output. Each experiment was carried out first without and then with additional IABP support.
RESULTS: The simultaneous use of ECMO and IABP is feasible for antegrade perfusion, where the IABP leads to an increase of blood pressure in the coronary arteries. In addition, the myocardial oxygen supply improves. By contrast, the use of an IABP in retrograde perfusion leads to a reduction of blood pressure in the LAD and to a reduced oxygen supply. A comparison between antegrade and retrograde perfusion with IABP support showed significantly better mean arterial pressure in the LAD for antegrade perfusion. Without IABP, blood pressure in the LAD was better in retrograde perfusion.
CONCLUSION: In antegrade perfusion the simultaneous use of IABP and ECMO is useful. In retrograde perfusion IABP impairs the mean arterial pressure and consequently the perfusion of the coronary arteries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25168417     DOI: 10.1007/s00063-014-0408-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  19 in total

Review 1.  Intra-aortic balloon counterpulsation.

Authors:  Jeffrey C Trost; L David Hillis
Journal:  Am J Cardiol       Date:  2006-03-20       Impact factor: 2.778

2.  Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients.

Authors:  Richard Cheng; Rory Hachamovitch; Michelle Kittleson; Jignesh Patel; Francisco Arabia; Jaime Moriguchi; Fardad Esmailian; Babak Azarbal
Journal:  Ann Thorac Surg       Date:  2013-11-08       Impact factor: 4.330

3.  Pulsatile cardiopulmonary bypass with intra-aortic balloon pump improves organ function and reduces endothelial activation.

Authors:  Giuseppe Filiberto Serraino; Roberto Marsico; Giuseppe Musolino; Valeria Ventura; Elio Gulletta; Pasquale Santè; Attilio Renzulli
Journal:  Circ J       Date:  2012-03-07       Impact factor: 2.993

4.  Severe intra-aortic balloon pump complications: a single-center 12-year experience.

Authors:  Luca Severi; Paola Vaccaro; Marco Covotta; Giovanni Landoni; Rosalba Lembo; Antonio Menichetti
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-03-22       Impact factor: 2.628

5.  Clinical outcome after mitral valve surgery due to ischemic papillary muscle rupture.

Authors:  Thomas Schroeter; Sven Lehmann; Martin Misfeld; Michael Borger; Sreekumar Subramanian; Friedrich W Mohr; Farhad Bakthiary
Journal:  Ann Thorac Surg       Date:  2012-12-05       Impact factor: 4.330

6.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Antoinette de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Bernward Lauer; Michael Böhm; Henning Ebelt; Steffen Schneider; Karl Werdan; Gerhard Schuler
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

Review 7.  Current status of percutaneous ventricular assist devices for cardiogenic shock.

Authors:  Sukhdeep S Basra; Pranav Loyalka; Biswajit Kar
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

8.  Influence of different flow modi during extracorporeal circulation on endothelial-derived vasoactive substances.

Authors:  C H Knothe; J Boldt; B Zickmann; S Konstantinov; P Dick; F Dapper; G Hempelmann
Journal:  Perfusion       Date:  1995-07       Impact factor: 1.972

9.  Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit.

Authors:  Sion K Roy; Edward W Howard; Julio A Panza; Howard A Cooper
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882

10.  Coronary versus carotid blood flow and coronary perfusion pressure in a pig model of prolonged cardiac arrest treated by different modes of venoarterial ECMO and intraaortic balloon counterpulsation.

Authors:  Jan Bělohlávek; Mikuláš Mlček; Michal Huptych; Tomáš Svoboda; Stěpán Havránek; Petr Ošt'ádal; Tomáš Bouček; Tomáš Kovárník; František Mlejnský; Vratislav Mrázek; Marek Bělohlávek; Michael Aschermann; Aleš Linhart; Otomar Kittnar
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

View more
  2 in total

Review 1.  Pitfalls of cannulation for extracorporeal life support: review of the literature and illustrative case presentation.

Authors:  Martin Geyer; Bernhard Gohrbandt; Ingo Sagoschen; Thomas Hartmann; Felix Post; Christian-Friedrich Vahl; Thomas Münzel
Journal:  J Artif Organs       Date:  2017-11-09       Impact factor: 1.731

Review 2.  Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure.

Authors:  William E Lawson; Michael Koo
Journal:  Clin Med Insights Cardiol       Date:  2015-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.